Revlis Biotech Company Limited
Our mission is to bring health management to individuals. We aim to position ourselves as a leading healthcare company by leveraging non-invasive technology, artificial intelligence algorithm, and big data processing for personalized service.
Founded in 2003, Revlis Biotech Company Ltd. embarked on the development of health and medical products. Cmate, a portable Gen I ECG and the company’s first commercial medical product, has obtained medical grade certification necessary for our launch in 2012. The scalability of our technology and service platform will enable us to expand our product roadmap from fully medical to health & wellness solutions which we are showcasing this year at Arab Health 2022.